Exceptional response to the ATR inhibitor, camonsertib, in a patient with ALT+ metastatic melanoma by Natalie Y. L. Ngoi, Ian M. Silverman, Adrienne Johnson, Chenfeng Meng, Joseph D. Schonhoft, Michal Zimmermann, Danielle Ulanet, Hyeyeon Kim, Carlos Torrado, Carolina Salguero, Christian Valladolid Brown, Jordi Rodon, Victoria Rimkunas, Maria Koehler, Timothy A. Yap

Get full text